4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-25-001025
President and CEO sold 9,536 shares at an average $30.13 ($287,316)
- President and CEO acquired 9,536 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/primarydocument.xml…